References
1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG and Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet . 2006;368:1005-11.
2. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW and Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol . 1997;29:630-4.
3. Roberts WC and Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation . 2005;111:920-5.
4. Beppu S, Suzuki S, Matsuda H, Ohmori F, Nagata S and Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am J Cardiol . 1993;71:322-7.
5. Nguyen V, Cimadevilla C, Estellat C, Codogno I, Huart V, Benessiano J, Duval X, Pibarot P, Clavel MA, Enriquez-Sarano M, Vahanian A and Messika-Zeitoun D. Haemodynamic and anatomic progression of aortic stenosis. Heart . 2015;101:943-7.
6. Bahler RC, Desser DR, Finkelhor RS, Brener SJ and Youssefi M. Factors leading to progression of valvular aortic stenosis. Am J Cardiol . 1999;84:1044-8.
7. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G and Baumgartner H. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J . 2004;25:199-205.
8. Capoulade R, Chan KL, Yeang C, Mathieu P, Bosse Y, Dumesnil JG, Tam JW, Teo KK, Mahmut A, Yang X, Witztum JL, Arsenault BJ, Despres JP, Pibarot P and Tsimikas S. Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis. J Am Coll Cardiol . 2015;66:1236-1246.
9. Shen M, Tastet L, Capoulade R, Arsenault M, Bedard E, Clavel MA and Pibarot P. Effect of bicuspid aortic valve phenotype on progression of aortic stenosis. Eur Heart J Cardiovasc Imaging . 2020;21:727-734.
10. Ryu DR, Park SJ, Han H, Lee HJ, Chang SA, Choi JO, Lee SC, Park SW and Oh JK. Progression rate of aortic valve stenosis in korean patients.J Cardiovasc Ultrasound . 2010;18:127-33.
11. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J and Investigators A. Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation . 2010;121:306-14.
12. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE and Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.Med Care . 2005;43:1130-9.
13. Palta S, Pai AM, Gill KS and Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention.Circulation . 2000;101:2497-502.
14. Kim D, Chae D, Shim CY, Cho IJ, Hong GR, Park K and Ha JW. Predicting Disease Progression in Patients with Bicuspid Aortic Stenosis Using Mathematical Modeling. J Clin Med . 2019;8.
15. Abdelbaky A, Corsini E, Figueroa AL, Subramanian S, Fontanez S, Emami H, Hoffmann U, Narula J and Tawakol A. Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study.Atherosclerosis . 2015;238:165-72.
16. O’Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE and Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ’degenerative’ valvular aortic stenosis.Arterioscler Thromb Vasc Biol . 1996;16:523-32.
17. Venardos N, Nadlonek NA, Zhan Q, Weyant MJ, Reece TB, Meng X and Fullerton DA. Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation. J Surg Res . 2014;190:1-8.
18. Cote N, Mahmut A, Bosse Y, Couture C, Page S, Trahan S, Boulanger MC, Fournier D, Pibarot P and Mathieu P. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation . 2013;36:573-81.
19. Tastet L, Capoulade R, Clavel MA, Larose E, Shen M, Dahou A, Arsenault M, Mathieu P, Bedard E, Dumesnil JG, Tremblay A, Bosse Y, Despres JP and Pibarot P. Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study. Eur Heart J Cardiovasc Imaging . 2017;18:70-78.
20. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM and Pibarot P. Calcific aortic stenosis. Nat Rev Dis Primers . 2016;2:16006.
21. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, Probstfield JL, Bertoni AG, Budoff MJ and O’Brien KD. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation . 2006;113:2113-9.
22. Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo CL, Garner HR, Merrill WH, Hinton RB and Garg V. Inhibitory role of Notch1 in calcific aortic valve disease. PLoS One . 2011;6:e27743.
23. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD, Jr. and Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes . 2009;2:533-9.
24. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Barwolf C, Boersma E, Ravaud P and Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J . 2005;26:2714-20.
25. Davies RR, Kaple RK, Mandapati D, Gallo A, Botta DM, Jr., Elefteriades JA and Coady MA. Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve.Ann Thorac Surg . 2007;83:1338-44.